MétaCan
Menu
Back to cohort
Record W2801534920 · doi:10.1093/eurheartj/ehy182

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

2018· review· en· W2801534920 on OpenAlexafffund
François Mach, Kausik K. Ray, Olov Wiklund, Alberto Corsini, Alberico L. Catapano, Éric Bruckert, Guy De Backer, Robert A. Hegele, G. Kees Hovingh, Terry A. Jacobson, Ronald M. Krauss, Ulrich Laufs, Lawrence A. Leiter, Winfried März, Børge G. Nordestgaard, Frederick J. Raal, Michael Roden, Raúl D. Santos, Evan A. Stein, Erik S.G. Stroes, Lâle Tokgözoğlu, Georgirene D. Vladutiu, Bariş Gencer, Jane K. Stock, Henry N. Ginsberg, M. John Chapman

Bibliographic record

VenueEuropean Heart Journal · 2018
Typereview
Languageen
FieldMedicine
TopicLipoproteins and Cardiovascular Health
Canadian institutionsUniversity of TorontoSt. Michael's HospitalWestern University
FundersEsperion TherapeuticsServierMylanMedicines CompanyRegeneron PharmaceuticalsSanofiKowa CompanyDanoneGenentechValeant Pharmaceuticals InternationalQuest DiagnosticsAmgenPfizerAbbott DiagnosticsEuropean Atherosclerosis SocietyAstraZenecaEli Lilly and Company
KeywordsMedicineStroke (engine)Adverse effectRenal functionStatinHomeostasisInternal medicineDiabetes mellitusCardiologyEndocrinology

Abstract

fetched live from OpenAlex

Aims: To objectively appraise evidence for possible adverse effects of long-term statin therapy on glucose homeostasis, cognitive, renal and hepatic function, and risk for haemorrhagic stroke or cataract. Methods and results: A literature search covering 2000-2017 was performed. The Panel critically appraised the data and agreed by consensus on the categorization of reported adverse effects. Randomized controlled trials (RCTs) and genetic studies show that statin therapy is associated with a modest increase in the risk of new-onset diabetes mellitus (about one per thousand patient-years), generally defined by laboratory findings (glycated haemoglobin ≥6.5); this risk is significantly higher in the metabolic syndrome or prediabetes. Statin treatment does not adversely affect cognitive function, even at very low levels of low-density lipoprotein cholesterol and is not associated with clinically significant deterioration of renal function, or development of cataract. Transient increases in liver enzymes occur in 0.5-2% of patients taking statins but are not clinically relevant; idiosyncratic liver injury due to statins is very rare and causality difficult to prove. The evidence base does not support an increased risk of haemorrhagic stroke in individuals without cerebrovascular disease; a small increase in risk was suggested by the Stroke Prevention by Aggressive Reduction of Cholesterol Levels study in subjects with prior stroke but has not been confirmed in the substantive evidence base of RCTs, cohort studies and case-control studies. Conclusion: Long-term statin treatment is remarkably safe with a low risk of clinically relevant adverse effects as defined above; statin-associated muscle symptoms were discussed in a previous Consensus Statement. Importantly, the established cardiovascular benefits of statin therapy far outweigh the risk of adverse effects.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.064
metaresearch head score (Gemma)0.141
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.064
Threshold uncertainty score0.336

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0640.141
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0050.006
Bibliometrics0.0100.006
Science and technology studies0.0010.003
Scholarly communication0.0050.004
Open science0.0020.003
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.055
GPT teacher head0.329
Teacher spread0.274 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations381
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueEuropean Heart JournalSame topicLipoproteins and Cardiovascular HealthFrench-language works237,207